CA1085291A - Fixed haptoglobin preparations - Google Patents

Fixed haptoglobin preparations

Info

Publication number
CA1085291A
CA1085291A CA283,177A CA283177A CA1085291A CA 1085291 A CA1085291 A CA 1085291A CA 283177 A CA283177 A CA 283177A CA 1085291 A CA1085291 A CA 1085291A
Authority
CA
Canada
Prior art keywords
haptoglobin
insolubilized
fibrinogen
bifunctional compound
thrombin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
CA283,177A
Other languages
English (en)
French (fr)
Inventor
Satoshi Funakoshi
Takao Oomura
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Tanabe Pharma Corp
Original Assignee
Green Cross Corp Japan
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Green Cross Corp Japan filed Critical Green Cross Corp Japan
Application granted granted Critical
Publication of CA1085291A publication Critical patent/CA1085291A/en
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/795Porphyrin- or corrin-ring-containing peptides
    • C07K14/805Haemoglobins; Myoglobins
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N11/00Carrier-bound or immobilised enzymes; Carrier-bound or immobilised microbial cells; Preparation thereof
    • C12N11/02Enzymes or microbial cells immobilised on or in an organic carrier
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/81Carrier - bound or immobilized peptides or proteins and the preparation thereof, e.g. biological cell or cell fragment as carrier
    • Y10S530/812Peptides or proteins is immobilized on, or in, an organic carrier
    • Y10S530/815Carrier is a synthetic polymer

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Biomedical Technology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • External Artificial Organs (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
CA283,177A 1976-08-27 1977-07-20 Fixed haptoglobin preparations Expired CA1085291A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP10276376A JPS5329908A (en) 1976-08-27 1976-08-27 Immobilized haptoglobin preparation
JP102763/76 1976-08-27

Publications (1)

Publication Number Publication Date
CA1085291A true CA1085291A (en) 1980-09-09

Family

ID=14336221

Family Applications (1)

Application Number Title Priority Date Filing Date
CA283,177A Expired CA1085291A (en) 1976-08-27 1977-07-20 Fixed haptoglobin preparations

Country Status (12)

Country Link
US (1) US4113853A (Direct)
JP (1) JPS5329908A (Direct)
BE (1) BE857021A (Direct)
CA (1) CA1085291A (Direct)
CH (1) CH632930A5 (Direct)
DE (1) DE2732437C3 (Direct)
ES (1) ES460861A1 (Direct)
FR (1) FR2362861A1 (Direct)
GB (1) GB1551646A (Direct)
LU (1) LU77802A1 (Direct)
NL (1) NL176637C (Direct)
SE (1) SE446430B (Direct)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4462989A (en) * 1981-05-04 1984-07-31 Evreka, Inc. Method and agents for arresting infection
US4442655A (en) * 1981-06-25 1984-04-17 Serapharm Michael Stroetmann Fibrinogen-containing dry preparation, manufacture and use thereof
US5464814A (en) * 1986-06-20 1995-11-07 Northfield Laboratories, Inc. Acellular red blood cell substitute
ATE302019T1 (de) * 1997-02-28 2005-09-15 Univ California Verfahren und zusammensetzungen zur optimierung des sauerstofftransportes in zellfreien systemen
US20050164915A1 (en) * 2002-04-01 2005-07-28 Sangart, Inc. Compositions for oxygen transport comprising a high oxygen affinity modified hemoglobin
US20030153491A1 (en) * 2002-01-11 2003-08-14 Winslow Robert M. Methods and compositions for oxygen transport comprising a high oxygen affinity modified hemoglobin
JP3912206B2 (ja) * 2002-07-05 2007-05-09 株式会社日立製作所 筒内直接燃料噴射装置用燃料ポンプ
RU2337705C2 (ru) * 2003-01-29 2008-11-10 Нортфилд Лэборэтериз, Инк. Растворы полимеризованного гемоглобина с пониженным количеством тетрамера и способ их получения
US20070196810A1 (en) * 2006-01-24 2007-08-23 Northfield Laboratories Inc. Polymerized Hemoglobin Media and its Use in Isolation and Transplantation of Islet Cells
US20090004159A1 (en) * 2006-01-24 2009-01-01 The Board Of Trustees Of The University Of Illinoi Polymerized Hemoglobin Media and Its Use in Isolation and Transplantation of Islet Cells

Also Published As

Publication number Publication date
LU77802A1 (Direct) 1977-10-25
ES460861A1 (es) 1978-04-16
CH632930A5 (de) 1982-11-15
JPS5523806B2 (Direct) 1980-06-25
NL176637C (nl) 1985-05-17
DE2732437C3 (de) 1979-09-27
FR2362861B1 (Direct) 1980-02-15
FR2362861A1 (fr) 1978-03-24
NL176637B (nl) 1984-12-17
SE7707889L (sv) 1978-02-28
DE2732437B2 (de) 1979-02-01
JPS5329908A (en) 1978-03-20
US4113853A (en) 1978-09-12
BE857021A (fr) 1977-11-14
SE446430B (sv) 1986-09-15
GB1551646A (en) 1979-08-30
NL7708024A (nl) 1978-03-01
DE2732437A1 (de) 1978-03-02

Similar Documents

Publication Publication Date Title
US4315906A (en) Cold insoluble globulin, its purification and use
Edwards et al. Tri (n-butyl) phosphate/detergent treatment of licensed therapeutic and experimental blood derivatives
CA1085291A (en) Fixed haptoglobin preparations
JPS645010B2 (Direct)
US6866846B1 (en) Patient-specific immunoadsorbers for the extracorporeal apheresis and methods for their preparation
US4075193A (en) Process for producing intravenous immune globulin
JPS5951220A (ja) 新規なプラスミノ−ゲン・アクチベ−タ−およびその製法ならびにこれを含有する薬剤
CA1321750C (en) Therapeutic enzymes
JPH02504587A (ja) 7a因子に富む画分の製造方法及び医薬としてのその用途
WO1990004416A1 (en) Specific removal of ldl from blood
GB2192633A (en) Endotoxin removal
Liau et al. Evaluation of monoclonal antifibrin antibodies by their binding to human blood clots
KR810000882B1 (ko) 고정화(固定化) 햅토글로빈의 제조법
US4608253A (en) Process for removing immune complex in blood by use of the immobilized pepsin
Comfort et al. The influence of bond chemistry on immobilized enzyme systems for ex vivo use
JPS62191042A (ja) 血液凝固第8因子吸着体およびそれを用いた血液凝固第8因子の精製法
JPS59118717A (ja) プラスミノーゲン活性化剤
EP0436717B1 (en) System for use in a method of therapeutic or diagnostic treatment
SU979508A1 (ru) Способ получени иммобилизованного плазминогена
JPS6114466B2 (Direct)
RU2098140C1 (ru) Способ проведения экстракорпоральной иммуносорбции
US4816409A (en) Method of eliminating tumor cells and device therefor
JPH0372309B2 (Direct)
Callegaro et al. Selective detoxification: hemoperfusion on antiphenobarbital antibody immobilized on solid phase
Azhari et al. Specific removal of paraquat by hemoperfusion through antiparaquat conjugated agarose‐polyacrolein microsphere beads

Legal Events

Date Code Title Description
MKEX Expiry